Human solCD39 inhibits injury-induced development of neointimal hyperplasia

scientific article published on 18 December 2009

Human solCD39 inhibits injury-induced development of neointimal hyperplasia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1160/TH09-05-0305
P932PMC publication ID2847853
P698PubMed publication ID20024507

P2093author name stringH Shen
A J Marcus
R Kraemer
R K Upmacis
J H F Drosopoulos
E Musi
P2860cites workPlatelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2.Q52939233
Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular InjuryQ56944225
CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima FormationQ61612314
Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteriesQ64379610
Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survivalQ64380399
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injuryQ72097139
Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytesQ73267219
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophilsQ73435130
Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitmentQ73861917
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injuryQ73919572
Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activityQ74462843
The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structureQ77229195
Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutantsQ79995310
P2 receptors in atherosclerosis and postangioplasty restenosisQ81060318
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterizationQ24323556
Identification and characterization of CD39/vascular ATP diphosphohydrolaseQ24336540
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)Q28166484
Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine ModelQ28185689
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainQ28192804
Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulationQ28594120
Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient miceQ30304455
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearanceQ30436506
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.Q30448825
Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alphaQ31919799
Real-time imaging of mechanically injured femoral artery in mice reveals a biphasic pattern of leukocyte accumulationQ33266721
Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasiaQ33342172
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantationQ33784839
Roles of Asp54 and Asp213 in Ca2+ utilization by soluble human CD39/ecto-nucleotidaseQ34149723
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosisQ34171790
Leukocyte-endothelial cell interactions in the inflammatory responseQ34633418
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.Q34769242
P2 receptors in cardiovascular regulation and diseaseQ36464824
CD39/NTPDase-1 activity and expression in normal leukocytesQ36479951
Platelet-leukocyte interactions in inflammation and atherothrombosisQ36752801
Platelets and endothelial cellsQ36752804
PECAM-1: a multi-functional molecule in inflammation and vascular biologyQ36943068
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseasesQ37307308
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.Q37381379
Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.Q41761170
Comparison of ICAM-1 and VCAM-1 expression in various human endothelial cell types and smooth muscle cellsQ42464591
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humansQ44513178
Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human bloodQ46596616
Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in ratsQ48370949
Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory propertiesQ48450718
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.Q50324471
Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening.Q50523399
P433issue2
P304page(s)426-434
P577publication date2009-12-18
P1433published inThrombosis and HaemostasisQ15724413
P1476titleHuman solCD39 inhibits injury-induced development of neointimal hyperplasia
P478volume103

Reverse relations

cites work (P2860)
Q34376573A study of the imbalance in B cell-expressed nucleoside triphosphate diphosphohydrolase 1-induced ADP degradation in graft injury during acute antibody-mediated rejection
Q58102990ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP
Q35779631In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications
Q89029585Mechanism of Nucleoside Triphosphate Diphosphohydrolase-1-Associated Imbalance in Adenosine Diphosphate Degradation, B-Cell Activation, and Related Injury During Acute Antibody-Mediated Rejection
Q67406317Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.
Q43102079Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk
Q34667425Proteomic identification of biomarkers of vascular injury.
Q47994855Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization